Member Info for stephen11

It’s been in an RNS from Conrad.

I’m sure we will hear at 7.04am.

The big daddy - Indonesian Gov approval can’t be far away!

- This is one of the more important GDR RNSs for a long-term holder because it is not about a product or trial — it is about control, confidence, and future direction of the company.

- David Nugent has:

*funded the company

*increased stake repeatedly

*joined the board

*waived fees until EBITDA positive

*That is not normal AIM behaviour for a casual investor

*He believes commercialisation is real and states same: “two point-of-care pharmacogenetic tests now on the market which offer highly promising commercial opportunities”

*He's seen under the bonnet and likes what he sees

GLA.

Stephen11.

- Great to see David Nugent take up the seat of Non-Executive Director.

- I loved the part where it says he won’t accept a salary until we are EBIDTA positive.

- If that’s not commitment and skin in the game then I don’t know what is.

- DN is the real deal.

- FDA submission will be next.

GLA.

Stephen11.

FDA submission will be that catalyst.

The AIM market loves the FDA - take a look at the graph when GDR submitted the Covid test in conjunction with Beckman Coulter.

Sadly - the Americans favoured there own tests, but we have no viable competitors for this test.

- Must be due soon?

CRD have RNS the major contractor agreement.

Another milestone met - I’d expect Indonesian Government approval to follow very soon.

GLA.

Stephen11.

@@@@Read between the lines@@@@

The Gas Transportation Agreement will be ready in the “coming weeks,” says the RNS

This is a strong near-term tell!

Why it matters:

It’s one of the final commercial agreements and is tied closely to regulatory and operational readiness.

I.e., Read-through:

If this is signed = approvals from the Indonesian Government are likely close behind or aligned. This will be the big catalyst were 0.0015 could we retested.

GLA.

Stephen11.

@@I have tracked back and reviewed the most recent company RNS reports - here is a summary of expected news:

- Near-term: Mako cash payment (imminent)

- US$5m to WNEL already triggered

- EME entitled: 8.5% = $425k

RNS said

"cash payments of approx $0.76 due in coming months (net adjustments apply)"

- That was a while back - could land anytime

**Indonesian Government Approval (this is the BIG one)

- Required approvals:

- PI transfers

- SPV transfers

- Farmout completion

Previous RNS reports give clues:

- "subject to customary conditions precedent"

- "approval from Ministry of Energy and Mineral Resources"

These could land at any time, as its in Indonesia's interests - brighter days ahead!

GLA.

Stephen11.

Agreed 👍 FB - David M is opening doors to other revenue streams. We need this.

£80,000 is not to be sneezed at.

Lots of £80,000 could follow.

But what it signifies is more important.

- The possibility of more charitable funding if this model is successful.

- Real world application.

- More data to support National Commissioning.

- A very positive RNS all round

GLA.

Stephen11.

Good point aga - make people hungry - sales = commission - win/win.

On the flip of that the National NHS funding pathways are also key - why not hire an expert to help navigate this - someone with a proven track record in pharmocogenics?

I'm very positive.

No need to fundraise for another 18 months, as per RNS - not many AIM companies can say that.

Proven resource and clear plan to market.

What's not to like?

I'm going to just sit with my pipe and slippers on and watch the SP rise over the next 2 years!

I'm very positive.

No need to fundraise for another 18 months, as per RNS - not many AIM companies can say that.

Proven resource and clear plan to market.

What's not to like?

I'm going to just sit with my pipe and slippers on and watch the SP rise over the next 2 years!

Basically the MMs had to up the SP price to attract sellers. They must have been short on stock to meet buying demand.

Bodes well for tomorrow - when the herd come in.

MMs were desperate for shares today - did anyone see the pattern?

- Despite a +50% move in the share price, the underlying trade data showed 289 million shares sold (£208k) versus 233 million bought (£164k), meaning selling actually outweighed buying.

- However, the price still rose sharply, which indicates this was not retail chasing but a classic case of liquidity harvesting — market makers were short of stock and had to push the price higher to attract sellers.

- This is a structurally bullish signal, suggesting underlying demand was stronger than it appears and that larger buyers were likely accumulating stock in the background.

- Big day ahead tomorrow: hold on to your golden tickets

GLA.

Stephen11.

What is the ask and sp for those with L2 out of interest?

Https://www.londonstockexchange.com/news-article/GDR/interim-results-to-31-december-2025/17524695

America's private health care system is extremely lucrative.

Besides, who's to say we won't get news on National Commissioning in April?

Good point Baznick.

Very apt on St. Patricks Day - i have more green from filters than O' Connell St Dublin today!

Brilliant update from David.

I hope this finally puts these idiotic and misleading comments to bed.

He's a good guy who saved us from a disastrous potential placing at 0.20p - had that taken place the SP would have been 5 times lower than today - that is the reality of the situation we were in.